Expressions of Chondroitin-4-sulfotransferase (CHST11) as well as other CHSTs in ovarian cancer samples are significantly higher than that in non-malignant ones, indicating poor prognosis [12]. This evidence concerns the gene CHST11 and ovarian cancer.